Breast cancer rates are rising in low-and middle-income countries (LMICs), yet 35 there is a lack of accessible and cost-effective treatment. As a result, the cancer burden 36 and death rates are highest in LMICs. In an effort to meet this need, our work presents the 37 design and feasibility of a low-cost cryoablation system using widely-available carbon 38 dioxide as the only consumable. This system uses an 8-gauge outer-diameter needle and 39 Joule-Thomson expansion to percutaneously necrose tissue with cryoablation. Bench top 40 experiments characterized temperature dynamics in ultrasound gel demonstrated that 41 isotherms greater than 2 cm were formed. Further, this system was applied to mammary 42 tumors in an in vivo rat model and necrosis was verified by histopathology. Finally, 43 freezing capacity under a large heat load was assessed with an in vivo porcine study, 44 where volumes of necrosis greater than 1.5 cm in diameter confirmed by histopathology 45 were induced in a highly perfused liver after two 7-minute freeze cycles. These results 46 demonstrate the feasibility of a carbon-dioxide based cryoablation system for improving 47 solid tumor treatment options in resource-constrained environments. 48 49 54 United States [2], the survival rate in low-and middle-income countries (LMICs) can 55 range from 64% in Saudi Arabia to 46% in Uganda to only 12% in The Gambia [3].
Introduction 50
Over 8 million cancer deaths occurred worldwide in 2012, with breast cancer 51 being the largest cause of cancer-related mortality for women with almost 500,000 52 reported deaths [1] . While diagnostic and treatment technologies in the developed world 53 have advanced such that the five-year survival rate for breast cancer is almost 90% in the 78 pressure. The gas undergoes rapid expansion and, due to the Joule-Thomson (JT) effect, 79 rapidly decreases temperature [16] . This expansion takes place inside a cryoprobe that is 80 percutaneously inserted into the cancerous tissue, and the temperature of the cryoprobe 81 causes an iceball as ice crystals form in surrounding cells (Fig 1) . This mechanism 82 introduces a temperature gradient in the iceball of -40 °C at the probe tip to 0 °C at the 83 edge of the iceball. Previous work has found that tissue held below -20 °C for over a 84 minute creates necrosis throughout the region [16] . Treatment is cycled with two freeze 85 cycles interrupted by a thaw cycle, which allows for both cell death via cellular 86 dehydration as well as through the formation of intracellular ice crystals [16] . Although cryoablation is promising for use in low-resource settings, most devices 91 are not designed with cost and resource constraints in mind or for use in LMICs. Current 92 cryoablation systems are too expensive for use in LMICs, as a single treatment can cost 93 upwards of $10,000, with over half of the cost coming from disposable, single-use parts 94 [17] . Furthermore, while argon gas is optimal for cryoablation, as it can reach 95 temperatures as low as its boiling point of -185.8 °C [16] , it is not available in LMICs.
96
Alternatively, carbon dioxide (CO 2 ) is available in most rural areas due to the carbonated 97 beverage industry and via the Joule-Thomson effect can reach a temperature as low as -98 78.5 °C [18] . In an effort to develop a practical system for tumor treatment in LMICs, we 99 have assessed the performance of a custom-designed cryoablation system optimized for 100 use with CO 2 ; it is the first percutaneous cryotherapy system to use only CO 2 as a 101 consumable. We report our results from three stages of experimental evaluation: bench 102 top experiment in an ultrasound gel tissue phantom, in vivo testing on mammary tumors 103 in a rat model with necrosis verified via histopathology, and assessment of freezing 104 capacity under a large heat load with an in vivo experiment in a porcine model.
105
Demonstrating the feasibility of cryoablation with CO 2 will potentially allow for 106 increased affordable and accessible breast cancer treatment globally. Our custom-designed cryosystem consists of two modules: the cryoprobe and the 111 gas-control module. The two modules are connected with nylon tubing and joined by 112 high-pressure brass pipefittings. The gas-control module is comprised of a high-pressure 113 fitting that directs CO 2 gas to the JT nozzle. This tubing allows gas release from a high-114 pressure environment into the cryoprobe chamber, which causes the cryoprobe to rapidly 115 cool. The cooled CO 2 gas then leaves the probe chamber and flows through the pre-116 cooling chamber that surrounds the gas inflow tube leading to the JT nozzle ( Fig 2) . The 117 pre-cooling process serves as a positive feedback to the cooling system by chilling the 118 inflow gas before it reaches the JT nozzle. After leaving the cryoprobe, the gas is released 119 into the atmosphere through an outflow tube. The gas control module is directly 120 connected to a tank of compressed CO 2 , and is comprised of a valve to control flow to the 121 cryoprobe and a pressure gauge that monitors the gas supply level in the tank. To begin a 122 freeze cycle, the valve on the CO 2 tank is opened, and the control valve is opened to 123 allow gas to flow through the system and cooling to begin. Initial tests were performed with the cryosystem in an ultrasound gel tissue 129 phantom for early validation in accordance with prior studies [19] . To evaluate device 130 performance, photographs of the iceball were taken every 30 seconds, and temperature of 131 the cryoprobe was monitored every 0.5 seconds using a thermocouple. In total, the 132 freezing capacity was evaluated through six trials per probe where the system completed 133 a 5-minute freeze cycle, a 3-minute thaw cycle, and then a second 5-minute freeze cycle.
134
For each test, the given probe was submerged in a beaker filled with 400 mL of Products, Inc.) at 5 weeks and 7 weeks of age. Similar to previous studies [22, 23] , 146 between one and three tumors were induced per rat, each of which was treated in separate 147 procedures. A total of ten mammary tumors in nine rats were treated by cryoablation. To 148 determine the extent of necrosis caused by the puncture of the cryoprobe rather than the 149 freezing, one tumor was selected at random as a no-treatment control (no freeze) in which 150 no CO 2 was released through the system, but all other procedural steps were followed 151 including needle insertion and elapsed time.
152
All procedures were performed in the veterinary operating room aided by a 153 trained surgeon, and each rat was anesthetized throughout the procedure. The rat was 154 placed on a heating pad to stabilize body temperature and a rectal thermometer was used 155 to monitor core body temperature. The tumors were surgically exposed such that each 156 tumor was separated from the skin, keeping any large blood vessels intact. After the 157 majority of the tumor was separated from the skin, petroleum jelly-coated gauze was 158 placed between the tumor and the skin to act as a thermal insulator to prevent cold injury 159 to the rat's skin (Fig 3) . temperature was monitored using a thermocouple during the procedure. 164 Prior to cryoprobe insertion, a trocar was used as a guide for the cryoprobe along 165 the longest axis of the tumor. Then, the cryoprobe was inserted into the tumor and a 166 thermocouple was placed 0.5 cm from the probe surface to measure tumor temperature.
167
The control valve was then turned on and CO 2 flowed, rapidly cooling the device and the 168 adjacent tissue. To ensure the tumor exposure and subsequent necrosis, the first freeze 169 cycle continued until the temperature from the thermocouple stabilized below -30 °C for 170 at least one minute with a maximum freezing time of 7 minutes [21] . Then, the control 171 valve was turned off for a 3-minute thaw cycle followed by the control valve being 172 turned on for a secondary freeze cycle defined by the same temperature and time 173 requirement as the first freeze cycle. After the second freeze, the control valve was turned 174 off and the tumor was allowed to thaw to 20 °C followed by removal of the cryoprobe.
175
The wounds were closed with surgical clips and the tumor remained in situ for a analogous to a human breast, similar to previous studies [24, 25] .
184
All procedures were performed with aseptic technique by a veterinarian and 185 interventional radiologist. The swine was sedated and an IV catheter was introduced to 186 administer antibiotics and anesthetic induction. The pig was intubated and general 187 anesthesia was maintained with isoflurane anesthesia with mechanical ventilation. The 188 swine was placed in a supine position, and a midline incision was used rather than percutaneous insertion of the probe through the skin, as the goal was to freeze only the 190 liver tissue rather than the skin, muscle and fatty tissue anterior to the liver.
191
A trocar was used as a guide to enter the liver under ultrasonic guidance and then 192 the cryoprobe was inserted. The device was positioned and CO 2 was allowed to flow.
193
Gauze soaked in warm saline was placed near the skin to aid in preventing skin necrosis.
194
The iceball growth was monitored via ultrasound imaging and the timing of the freeze-195 thaw cycles was determined by the plateau of the iceball growth. Two 7-minute freeze 196 cycles were performed with a 4-minute thaw cycle between the freeze cycles (Fig 4) . Tissue damage was seen in the sectioned portions of liver with defined borders 229 between healthy and necrotic tissue (Fig 6) .
230 Fig 6. A section of the liver after perfusion and fixation where cryoablation was   231 performed. Defined borders are seen between the dark necrotic tissue and the 232 lighter healthy tissue. 233 We observed a rapid transition from necrotic tissue to relatively normal liver tissue, as is 234 demarcated by the dashed line in Fig 7. Histopathology examination of the ablated area 235 confirmed varied gradients of necrosis (Fig 8) . The minimum diameter of the necrotic region, from Region A out to Region C, was 247 measured to be 2.08 cm as seen in Fig 8. As the plane of the tissue sections was not 248 strictly perpendicular to the tract of the cryoprobe, the minimum diameter was used to 249 determine the minimum cross sectional area of 3.4 cm 2 . As the iceball forms in a 250 cylindrically symmetrical shape, any cross section will result in an ellipse with a minor 251 diameter equal to the diameter of the cylinder. 
